Exploring nationwide trends in multiple myeloma (MM), autologous stem cell transplants (ASCTs), chimeric antigen receptor T-cell (CAR-T) therapy and coronavirus disease 2019 (COVID-19) in ...

New findings show that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment outcomes for pediatric patients with B-cell acute lymphoblastic leukemia (B ...

B-cell maturation antigen–directed chimeric antigen receptor (CAR) T-cell therapy demonstrated safety in patients with multiple myeloma (MM) and central nervous system (CNS) involvement, achieving an ...

As scientists uncover how age-altered antibodies ignite inflammation and tissue decline, a new era of immune-based anti-aging therapies is beginning to emerge. Aging affects B cells and induces ...

In a clinical trial of 7 patients, anti-BCMA only CAR-T cell treated patients with refractory lupus nephritis safely and effectively. Anti-B cell maturation antigen (BCMA)-targeting chimeric antigen ...

The fear of cancer stems from the dread that it can recur at any time, even after treatment. A South Korean research team has unveiled a new personalized cancer vaccine technology that enables the ...